United States
Notwithstanding unfavorable changes to the Code, capital gain treatment is still available on the sale of patents in certain scenarios.
Tax highlights for life sciences companies as you prepare for year-end filing and a look ahead to prepare for 2019.
Enhanced tax deduction may be available for drug inventory contributions made to certain charitable organizations.
The IRS is reconsidering the traditional rule requiring revenue to satisfy the active trade or business requirement of section 355.
Life sciences companies making payments to related foreign parties should be aware of how to determine the gross receipts calculation.
Missed our recent webcast on how the Tax Cuts and Jobs Act will affect life sciences companies? Check out our recap.
This recorded webcast provides an overview of the key provisions of the new tax bill and how they affect life sciences companies.
A review of IRS rulings on the proper treatment of similar expenses that were incurred by a pharmaceutical company.
The medical device tax is set to resume on Jan. 1, 2018, however a House bill was introduced to delay the tax another five years.
Tax highlights for life sciences companies as you prepare for year-end filing and a look ahead to prepare for 2018.
A recent opinion by the Advocate General (AG) for the European Court of Justice (ECJ) opens the door for pharmaceutical companies to potentially ...
California biotech firm sees larger corporate tax bill after Massachusetts high court determination that it was engaged in manufacturing.
Learn how RSM helped a pharmaceutical company realize better, timelier service through a tax outsourcing arrangement.
Our tax professionals take a holistic approach to understanding the overall needs of your life sciences business.